IAC Express 2009 |
Issue number 830: November 2, 2009 |
|
Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- Merck
announces decision not to resume production of its
monovalent measles, mumps, and rubella vaccines
- FDA authorizes emergency use of intravenous antiviral
Peramivir for 2009 H1N1 influenza virus infection
- MMWR
announces that November 2 is World Pneumonia Day
- In honor of World Pneumonia Day, IAC's Video of the Week
educates about pneumococcal disease and vaccine
- CDC posts Q&A on using H1N1 influenza vaccine in pregnant
women, H1N1 vaccine dosage chart, and much more
- CDC's ready-to-print influenza vaccination record card
made available on the 2009 H1N1 Flu website
- Important: During H1N1 influenza outbreak, administer
PPSV to all people with existing indications
- Immunization Techniques video (DVD or VHS) offers a great
way to give staff high-quality vaccination instruction
- Medical practices make a strong showing on IAC's Honor
Roll for Patient Safety, as do larger institutions
- AMA launches Web-based influenza health-assessment
program for patients and physicians
- November 17 webcast and teleconference on the impact of
infant meningococcal disease to feature renowned experts
- Keep
vaccinating against seasonal influenza!
- Seasonal influenza vaccine pocket guides--FREE!--from the
National Influenza Vaccine Summit
- Play a fast-paced vocabulary game, and help raise money
to purchase vaccine that prevents childhood pneumococcal
disease
- VISs for H1N1 influenza vaccines now in Hmong, Somali,
and Turkish
- Department of Health and Human Services' Healthy People
2020 objectives available for public comment
|
|
Abbreviations |
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
|
Issue 830: November 2, 2009 |
|
|
1. |
Merck announces decision not to resume production of its
monovalent measles, mumps, and rubella vaccines
On October 21, Merck posted a letter to
healthcare providers
on its website stating that on the counsel of ACIP and other
advisors, the company has decided not to resume production
of its monovalent measles, mumps, and rubella vaccines. A
portion of the letter is reprinted below.
In a related move, CDC posted "Q&As about Monovalent M-M-R
Vaccines" on its Vaccines Shortages & Delays web page. A
link to the Q&As is given at the end of this IAC Express
article.
October 21, 2009
Dear Health Care Provider:
MONOVALENT VACCINES NO LONGER AVAILABLE FOR MEASLES, MUMPS,
AND RUBELLA
Based on input from the Advisory Committee on Immunization
Practices (ACIP), professional societies, scientific
leaders, and customers, Merck has decided not to resume
production of Attenuvax (Measles Virus Vaccine Live),
Mumpsvax (Mumps Virus Vaccine Live), and Meruvax (Rubella
Virus Vaccine Live). This science-based decision will
support vaccination of the largest group of appropriate
individuals.
We will continue to focus necessary resources to ensure that
we can help meet current and future global and public health
needs for our combination measles, mumps, and rubella
vaccine, M-M-R II (Measles, Mumps, and Rubella Virus Vaccine
Live).
BACKGROUND AND RATIONALE
In 2008, Merck stopped making the 3 monovalent vaccines due
to manufacturing constraints and had announced plans to
resume production only if sufficient manufacturing resources
were available to do so without compromising supplies of M-M-R II.
The combination vaccine M-M-R II is recommended by the ACIP,
the American Academy of Pediatrics (AAP), and the American
Academy of Family Physicians (AAFP), and is preferred over
the monovalent vaccines because it eliminates the need for 3
separate injections and reduces the chance of delays in
helping protect against any of these potentially serious
diseases.
There is no medical reason to administer the measles, mumps,
and rubella antigens separately, and ACIP guidelines do not
support their use. . . .
To read Merck's complete letter, go to:
https://www.merckvaccines.com/monovalentMessage_102109.pdf
To access "Q&As about Monovalent M-M-R Vaccines," go to:
http://www.cdc.gov/vaccines/vac-gen/Shortages/mmr-faq-12-17-08.htm
Back to top |
|
|
2. |
FDA authorizes emergency use of intravenous antiviral
Peramivir for 2009 H1N1 influenza virus infection
On October 23, FDA issued a press announcement
titled " FDA
Authorizes Emergency Use of Intravenous Antiviral Peramivir
for 2009 H1N1 Influenza for Certain Patients, Settings."
Portions of the press announcement are reprinted below.
In a related move, CDC posted Q&As about Peramivir for
healthcare providers. A link to the Q&As is given at the end
of this IAC Express article.
The U.S. Food and Drug Administration announced today that,
in response to a request from the U.S. Centers for Disease
Control and Prevention, it has issued an emergency use
authorization (EUA) for the investigational antiviral drug
peramivir intravenous (IV) in certain adult and pediatric
patients with confirmed or suspected 2009 H1N1 influenza
infection who are admitted to a hospital. Specifically, IV
peramivir is authorized only for hospitalized adult and
pediatric patients for whom therapy with an IV drug is
clinically appropriate, based on one or more of the
following reasons:
- the patient is not responding to either oral or inhaled
antiviral therapy, or
- when drug delivery by a route other than an intravenous
route--e.g., enteral (absorbed by the intestines) or
inhaled--is not expected to be dependable or feasible;
- for adults only, when the clinician judges IV therapy is
appropriate due to other circumstances. . . .
To access the complete press announcement, go to:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187813.htm
To access "Peramivir IV Questions and Answers for Healthcare
Providers, go to:
http://www.cdc.gov/h1n1flu/EUA/pdf/peramivir_qa.pdf
Back to top |
|
|
3. |
MMWR announces that November 2 is World Pneumonia Day
CDC published "Announcement: World Pneumonia
Day--November
2, 2009" in the October 30 issue of MMWR. The announcement
is reprinted below in its entirety. Articles #4 and #14 in
this issue of IAC Express have additional information on
global childhood pneumococcal disease and World Pneumonia
Day.
Pneumonia kills more children than any other illness; of the
approximately 10 million children aged <5 years who die each
year worldwide, 2 million die from pneumonia. Streptococcus
pneumoniae (pneumococcus) and Haemophilus influenzae type b
(Hib) account for approximately half of pneumonia deaths
globally in children aged 1 month-5 years. Much of this
disease burden is vaccine-preventable. In the United States,
seven-valent pneumococcal conjugate and Hib vaccines are
recommended for infants and children aged <2 years as part
of the routine infant immunization schedule and have reduced
morbidity and mortality from pneumococcal and Hib disease.
Collaborative international efforts are expanding use of
these vaccines in developing countries.
Viruses such as respiratory syncytial virus, parainfluenza
virus, measles, and influenza also are a major cause of
pneumonia. Access to vaccines, antivirals, and supportive
healthcare measures reduces the burden of infections from
these viruses.
To raise awareness of the effects of pneumonia globally, the
first World Pneumonia Day, November 2, 2009, is being
promoted by a coalition of 40 major health, humanitarian
relief, advocacy, faith-based, government, and other
organizations; CDC and UNICEF are providing technical
assistance. Events are scheduled at CDC and elsewhere in the
United States, and in other countries. Additional
information is available at http://worldpneumoniaday.org
To access the announcement in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5842a6.htm
To access a ready-to-print (PDF) version of this issue of
MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5842.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP recommendations), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
|
|
4. |
In honor of World Pneumonia Day, IAC's Video of the Week
educates about pneumococcal disease and vaccine
IAC encourages IAC Express readers to watch a
4-minute video
created by the Global Alliance for Vaccines and Immunization
(GAVI Alliance). The video gives viewers a front-line look
at the fight to protect children from pneumococcal disease
using the first vaccine to be specifically designed for the
developing world.
The video will be available on the home page of IAC's
website through November 8. To access it, go to:
http://www.immunize.org and click on the image under the
words Video of the Week. It may take a few moments for the
video to begin playing; please be patient!
To learn more about pneumococcal disease and World Pneumonia
Day, go to:
http://worldpneumoniaday.org
Remember to bookmark IAC's home page to view a new video
every Monday. To view an IAC Video of the Week from the
past, go to the video archive at http://www.immunize.org/votw
Back to top |
|
|
5. |
CDC posts Q&A on using H1N1 influenza vaccine in pregnant
women, H1N1 vaccine dosage chart, and much more
CDC recently added or updated the following H1N1
influenza
information for healthcare professionals.
Use of Influenza A (H1N1) 2009 Monovalent Influenza Vaccine
in Pregnant Women
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm188099.htm
Influenza A (H1N1) 2009 Monovalent Vaccine Dosage Chart
http://www.cdc.gov/h1n1flu/pdf/monovalent_vaccine_dosage_chart.pdf
Prevention Of Pneumococcal Infections Secondary To Seasonal
And 2009 H1N1 Influenza Viruses Infection
http://www.cdc.gov/h1n1flu/vaccination/provider/provider_pneumococcal.htm
Questions and Answers: Emerging Infectious Diseases (EID)
article "Estimates of the Prevalence of Pandemic (H1N1)
2009, United States, April-July 2009"
http://www.cdc.gov/h1n1flu/eid_qa.htm
Peramivir IV Questions and Answers for Healthcare Providers
http://www.cdc.gov/h1n1flu/EUA/pdf/peramivir_qa.pdf
CMS Free Care Rule for 2009 H1N1 Influenza Vaccination
Questions and Answers: NEJM article "Hospitalized Patients
with 2009 H1N1 Influenza in the United States--April-June
2009"
http://www.cdc.gov/h1n1flu/njem_qa.htm
CDC's H1N1 Flu web section contains hundreds of documents
for healthcare professionals and the public. To access the
web section's home page, go to: http://www.cdc.gov/h1n1flu
To make it easy for you to keep up to date with
developments, IAC has gathered important information related
to H1N1 influenza into a single web section. To access this
resource, go to: http://www.immunize.org/h1n1
Back to top |
|
|
6. |
CDC's ready-to-print influenza vaccination record card
made available on the 2009 H1N1 Flu website
CDC recently made a slight revision and posted
its Influenza
Vaccination Record card on the "2009 H1N1 Flu: Free
Resources" section of its website. The card previously was
not available on the CDC website.
The printed version of the record card is packaged in
bundles of 100 and included with other ancillary supplies
that accompany each shipment of 100 doses of H1N1 vaccine.
Healthcare providers have discovered that more cards are
sometimes needed to compensate for the additional doses
necessary when children younger than age 3 years are given
the recommended 0.25 mL dose of FluZone from the 5.0 mL
vial, rather than the 0.5 mL dose that older persons are
given.
The card has space for healthcare providers to record
information for both H1N1 and seasonal influenza vaccine.
This allows providers who are administering only seasonal
vaccine to use the card to give their patients a record of
seasonal vaccination.
The online version of the record card can be printed on an
office printer or taken to a photocopy store. The link to a
PDF version of the card suitable for printing 6 cards to a
page, as well as instructions for use of the card, can be
found at http://www.cdc.gov/h1n1 Scroll down and click on a
hyperlink titled Free Resources. When you are on the Free
Resources web page, scroll down to the item titled "2009-10
Influenza Vaccination Record Card--October 30, 2009."
The card is also available on the website of the National
Influenza Vaccine Summit. For detailed information about the
card, including printing instructions, go to the paragraphs
under the subtitle "Influenza Vaccination Record card" at
http://www.preventinfluenza.org/profs_strategies.asp#record
To access a ready-to-print PDF version of the card directly
from the Summit's website, go to:
http://www.preventinfluenza.org/flu_record_card_2009.pdf
Back to top |
|
|
7. |
Important: During H1N1 influenza outbreak, administer
PPSV to all people with existing indications
CDC advises healthcare professionals that during
the current
outbreak of novel influenza A (H1N1), all people who have
existing indications for pneumococcal polysaccharide vaccine
(PPSV) should be vaccinated according to current ACIP
recommendations. This is important because people with
existing indications are not only at increased risk for
pneumococcal disease, but are also at increased risk for
serious complications from influenza.
CDC recently updated its guidance document "Interim guidance
for use of 23-valent pneumococcal polysaccharide vaccine
during novel influenza A (H1N1) outbreak." To access it, go
to:
http://www.cdc.gov/h1n1flu/guidance/ppsv_h1n1.htm
Also recently, CDC issued a comprehensive document on the
subject, "Prevention of pneumococcal infections secondary to
seasonal and 2009 H1N1 influenza virus infection." To access
it, go to:
http://www.cdc.gov/h1n1flu/vaccination/provider/provider_pneumococcal.htm
Back to top |
|
|
8. |
Immunization Techniques video (DVD or VHS) offers a great
way to give staff high-quality vaccination instruction
If your healthcare setting is vaccinating a lot
more people
than usual because of H1N1 influenza, this is a great time
for your staff to review the recommended immunization
techniques shown in the video Immunization Techniques: Safe,
Effective, Caring. This popular and highly lauded 35-minute
video offers healthcare providers a way to train their
staff--quickly, effectively, and affordably (only $10.50 for
each DVD or VHS ordered).
Developed in 2001 by the California Department of Health
Services Immunization Branch in collaboration with a team of
national experts, the video teaches best practices for
administering intramuscular (IM) and subcutaneous (SC)
vaccines to infants, children, and adults. PLEASE NOTE
however, that because the video was released in 2001, it
does NOT provide instruction on administering the nasal-spray influenza vaccines or the oral rotavirus vaccines.
These vaccines were licensed after 2001.
Available in DVD and VHS formats, the video is designed for
use as a "hands-on" instructional program for new staff, as
well as a refresher course for experienced healthcare
professionals. It discusses the following:
-
Anatomic sites
-
Choice of needle size
-
Vaccines and routes of administration
-
Demonstrations of infants, toddlers, kindergartners, and
adults being vaccinated
-
How to "draw up" doses of vaccine
TO ORDER OR FOR ADDITIONAL INFORMATION. The cost is $10.50
per copy of the DVD or VHS.
For additional information about the DVD, or to order online
or to download an order form, visit
http://www.immunize.org/shop/toolkit_iztechdvd.asp
For additional information about the VHS, or to order online
or to download an order form, visit
http://www.immunize.org/shop/toolkit_iztechvhs.asp
Back to top |
|
|
9. |
Medical practices make a strong showing on IAC's Honor
Roll for Patient Safety, as do larger institutions
Since October 19, when IAC Express last reported
on the
Honor Roll for Patient Safety, seven medical practices and
two hospitals have enrolled. The honor roll recognizes
medical practices, hospitals, professional organizations,
and government entities that have taken a stand for patient
safety by strengthening mandatory influenza vaccination
policies for healthcare workers.
Vaccination is one of the most effective ways to prevent
influenza transmission in healthcare settings, but U.S.
healthcare worker influenza vaccination rates have only
reached 50 percent. Key elements of the stronger policies
that have recently been initiated in some healthcare
settings are the inclusion of barrier measures to prevent
influenza transmission and the discontinuation of policies
that allowed workers to exempt themselves from influenza
vaccination because of their personal beliefs.
The seven medical practices that have joined since October
19 are Affiliates in Medical Specialties Medical Group, West
Hills, CA; Agape Outreach, Arlington, TX; Hometown Home
Health, Tulsa and Oklahoma City, OK; Longs Peak Family
Practice, Longmont, CO; NewYork-Presbyterian Hospital, NY;
Open Door Family Medical Centers, NY; and Woodcreek
Healthcare, Bonney Lake and Puyallup, WA.
The newly enrolled hospitals are Johns Hopkins Health
System, MD; and Spectrum Health Hospitals, Grand Rapids, MI.
To find out specific information on the mandates of these
organizations and previously enrolled organizations, go to:
http://www.immunize.org/laws/influenzahcw.asp
JOIN THE HONOR ROLL TODAY
To be included in the honor roll, your organization's
mandate must require influenza vaccination for employees and
must include serious measures to prevent transmission of
influenza from unvaccinated workers to patients. Such
measures might include a mask requirement, reassignment to
non-patient-care duties, or dismissal of the employee.
Fill out this online form to tell IAC about influenza
vaccination mandates in your healthcare setting:
http://www.immunize.org/laws/mandates.aspx
Back to top |
|
|
10. |
AMA launches Web-based influenza health-assessment
program for patients and physicians
On October 22, the American Medical Association
(AMA) issued
a press release titled "AMA Launches Nation's First
Comprehensive Web-Based Flu Health-Assessment Program for
Patients and Physicians." A portion of the press release is
reprinted below. A link to the health-assessment program,
called AMAfluhelp.org, is given at the end of this IAC
Express article.
To help patients and physicians better communicate and
improve care coordination, the American Medical Association
(AMA) today unveils AMAfluhelp.org, the nation's first
comprehensive web-based patient flu health-assessment
program. It walks patients through a series of questions to
determine the severity of their flu symptoms based upon the
latest Centers for Disease Control and Prevention
guidelines. Patients can choose to share their information
with their physician, as well as [with] family members and
loved ones. AMAfluhelp.org also provides a set of online
tools to help physicians monitor their patients' symptoms,
facilitate care and treatment decisions, and efficiently
manage their practices' patient flow. . . .
To access the complete press release, go to:
http://www.ama-assn.org/ama/pub/h1n1/news/ama-flu-help-release.shtml
To access the AMAfluhelp.org health-assessment program
directly, go to:
https://www.amafluhelp.org/public/consumer/home.aspx
Back to top |
|
|
11. |
November 17 webcast and teleconference on the impact of
infant meningococcal disease to feature renowned experts
The IMD Aware Coalition will host a
teleconference for
healthcare professionals on November 17 at 11AM ET. "IMD" is
the abbreviation for Infant Meningococcal Disease, a
potentially fatal bacterial infection that CDC estimates
affects 1,000-3,000 U.S. infants each year.
Speakers include Mathuram Santosham, MD, MPH, FAAP, Johns
Hopkins Bloomberg School of Public Health; Jennifer Shu, MD,
FAAP, American Academy of Pediatrics; Mary Beth Koslap-Petraco, DNC, PNP-BC, CPNP, National Association of
Pediatric Nurse Practitioners; Jerome Klein, MD, FAAP,
National Foundation for Infectious Diseases; Frankie Milley,
Meningitis Angels; and Lynn Bozof, National Meningitis
Foundation.
To register for the November 17 event, go to:
http://www.videonewswire.com/event.asp?id=63078
Back to top |
|
|
12. |
Keep vaccinating against seasonal influenza!
If you're wondering if you should continue to
vaccinate
against seasonal influenza now that H1N1 influenza vaccine
has become available, the answer is YES! The 2009 H1N1
influenza vaccine will not protect people against seasonal
influenza, and seasonal influenza vaccine will not protect
against H1N1 influenza.
Unfortunately, some healthcare facilities are having
difficulty finding available vaccine to purchase. Be assured
that though seasonal influenza vaccine may be in temporary
short supply in some settings right now, supplies are
expected to catch up to demand.
To assist providers in finding seasonal influenza vaccine
available for purchase, the National Influenza Vaccine
Summit supports IVATS (Influenza Vaccine Availability
Tracking System). IVATS provides information about vaccine
manufacturers and distributors with vaccine available for
purchase. To access this information in Excel spreadsheet
format, go to:
http://www.preventinfluenza.org/ivats/ivats_09_10.xls
Many resources regarding influenza disease and vaccination
are available to healthcare professionals and the public.
Following is a list of some of them.
To access the National Influenza Vaccine Summit website, go
to:
http://www.preventinfluenza.org
To access IAC's Seasonal Influenza web section, go to:
http://www.immunize.org/influenza
To access IAC's H1N1 Influenza web section, go to:
http://www.immunize.org/h1n1
To access CDC's Seasonal Flu web section, go to:
http://www.cdc.gov/flu
To access CDC's Novel H1N1 Flu web section, go to:
http://www.cdc.gov/h1n1flu
To access IAC's print pieces related to influenza, including
screening questionnaires, patient education pieces, and
sample standing orders, go to:
http://www.immunize.org/printmaterials/dis_inf.asp
Back to top |
|
|
13. |
Seasonal influenza vaccine pocket guides--FREE!--from the
National Influenza Vaccine Summit
With vaccination against 2009 H1N1 influenza
underway, it is
important to remember that seasonal influenza vaccination
efforts must continue. To aid in these efforts, the
Immunization Action Coalition is inviting IAC Express
readers to place orders now for the National Influenza
Vaccine Summit's 2009-10 Seasonal Influenza Vaccination
Pocket Information Guides. They're free!
These laminated, 3.75 x 6.75-inch, 2-color cards serve as a
convenient reference for front-line healthcare professionals
who vaccinate patients. The cards provide the following
information:
-
Indications, contraindications, and precautions for the
injectable and intranasal seasonal influenza vaccines
-
Populations targeted for seasonal influenza vaccination
-
Dosage and route of administration for all the various
seasonal influenza vaccine products
-
Talking points for discussing seasonal influenza
vaccination with patients
See an image of the seasonal influenza vaccine pocket guide
at
http://www.preventinfluenza.org/fluguide/pocketguide_flu.pdf
These pocket guides also serve as a reminder to keep giving
seasonal influenza vaccine throughout the influenza season
(through the spring months).
The Summit is also pleased to be able to offer pocket guides
for the administration of pneumococcal polysaccharide
vaccine (PPSV). See an image of the PPSV pocket guide at
http://www.immunize.org/ppvguide/pocketguide.pdf
Each of these pocket guides is designed to be used by
healthcare professionals only; THEY ARE NOT PATIENT
HANDOUTS.
HOW TO ORDER
Each order must be for a minimum of 100 pocket guides. Place
your order at http://www.preventinfluenza.org/pocketguides
There is no cost for the pocket guides, shipping, or
handling within the U.S. Quantities are limited, so to avoid
disappointment, place your order today!
If you have questions, email admininfo@immunize.org
BACKGROUND
These pocket guides were developed by, and are being
provided under the sponsorship of the National Influenza
Vaccine Summit, http://www.preventinfluenza.org The Summit
brings together public and private stakeholders to
facilitate and promote influenza vaccination. The pocket
guides are also distributed by many major medical, nursing,
and pharmacist organizations, specialty societies, state
health departments, Indian Health Service Area facilities,
Quality Improvement Organizations, Visiting Nurse
Associations, community vaccinators, and many others.
Thanks for your dedication to immunization, and don't forget
to keep vaccinating against seasonal influenza through the
spring months!
Back to top |
|
|
14. |
Play a fast-paced vocabulary game, and help raise money
to purchase vaccine that prevents childhood pneumococcal
disease
To draw attention to the plight of the 2 million
children
worldwide who die each year from pneumococcal disease, and
in observance of World Pneumonia Day, GiveVaccines.org will
donate all proceeds during the month of November to the
Global Coalition Against Child Pneumonia and the World
Pneumonia Day Coalition. Based in Orange, CA,
GiveVaccines.org is a non-profit organization that
administers a "free vaccines" vocabulary game.
All net proceeds from advertising revenues will be donated
to the GAVI Alliance and other organizations for the
purchase of life-saving vaccines. It is estimated that a
typical vaccine to prevent pneumonia will cost approximately
$0.15, which equates to 150 accumulative correct answers on
GiveVaccines.org. The whole idea of the interactive
vocabulary quiz is to have fun, expand one's vocabulary, and
at the same time provide the funds to purchase live-saving
vaccines for those in need.
Be sure to visit http://www.givevaccines.org as often as you
can and enjoy the vocabulary challenge.
For more information about GiveVaccines.org, go to:
http://www.givevaccines.org/about.php
Back to top |
|
|
15. |
VISs for H1N1 influenza vaccines now in Hmong, Somali,
and Turkish
Dated 10/2/09, the VISs for 2009 H1N1 inactivated
influenza
vaccine (injectable) and 2009 H1N1 live attenuated influenza
vaccine (nasal spray) are now available in Hmong, Somali,
and Turkish. IAC gratefully acknowledges the Minnesota
Department of Health for the Hmong and Somali translations
and Dr. Mustafa Konzanoglu and Dr. Murat Serbest for the
Turkish translations.
VISs FOR THE INJECTABLE 2009 H1N1 INFLUENZA VACCINE
To access the Hmong version of the VIS for the injectable
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/hm_h1n1_inact.pdf
To access the Somali version of the VIS for the injectable
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/so_h1n1_inact.pdf
To access the Turkish version of the VIS for the injectable
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/tu_h1n1_inact.pdf
To access the English version of the VIS for the injectable
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/h1n1_inactiveflu.pdf
NOTE: The VIS for injectable 2009 H1N1 influenza vaccine
comes in additional languages, including Spanish. To access
them, go to:
http://www.immunize.org/vis/vis_h1n1_inactive.asp Click on
the link to the pertinent language.
VISs FOR THE NASAL-SPRAY 2009 H1N1 INFLUENZA VACCINE
To access the Hmong version of the VIS for the nasal-spray
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/hm_h1n1_live.pdf
To access the Somali version of the VIS for the nasal-spray
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/so_h1n1_live.pdf
To access the Turkish version of the VIS for the nasal-spray
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/tu_h1n1_live.pdf
To access the English version of the VIS for the nasal-spray
2009 H1N1 influenza vaccine, go to:
http://www.immunize.org/vis/h1n1_liveflu.pdf
NOTE: The VIS for nasal-spray 2009 H1N1 influenza vaccine
comes in additional languages, including Spanish. To access
them, go to:
http://www.immunize.org/vis/vis_h1n1_live.asp Click on the
link to the pertinent language.
For information about the use of VISs, and for VISs in more
than 35 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
For general information about VISs from CDC's website go to:
http://www.cdc.gov/vaccines/pubs/vis
Back to top |
|
|
16. |
Department of Health and Human Services' Healthy People
2020 objectives available for public comment
The Department of Health and Human Services'
proposed
Healthy People 2020 objectives are now available online for
public comment. Healthy People provides science-based, 10-year national objectives for promoting health and preventing
disease.
To read the proposed Healthy People 2020 objectives by
topic, go to:
http://www.healthypeople.gov/hp2020/Objectives/TopicAreas.aspx
To access the public comment database, and to submit your
comments, go to:
http://www.healthypeople.gov/hp2020/Comments
For comprehensive information about Healthy People, go to:
http://www.healthypeople.gov
Back to top |
|
|
|